Peginterferon alfa-2a [clinicaltrials_resource:ea2504b16a94f43e40b345f0551d81c0]
clinicaltrials:NCT00006164A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV) [clinicaltrials:NCT00008463]clinicaltrials:NCT00023322clinicaltrials:NCT00028093Thymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin [clinicaltrials:NCT00039962]Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin [clinicaltrials:NCT00040027]Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV) [clinicaltrials:NCT00051077]Treatment of Hepatitis C in Hemophilic Patients With HIV [clinicaltrials:NCT00055341]clinicaltrials:NCT00056862ACCELERATE Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC) Infection. [clinicaltrials:NCT00077636]A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C Infection (CHC). [clinicaltrials:NCT00077649]clinicaltrials:NCT00078403Safety and Tolerability of Pegylated Interferon (PEG-IFN) Alfa-2a in HIV Infected People [clinicaltrials:NCT00078442]clinicaltrials:NCT00081770clinicaltrials:NCT00085917A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Ribavirin in Patients With Chronic Hepatitis C (CHC) Previously Treated With PEG-Intron + Ribavirin [clinicaltrials:NCT00087568]A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Enrolled in a Methadone Maintenance Treatment Program. [clinicaltrials:NCT00087594]PEAK Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC). [clinicaltrials:NCT00087607]clinicaltrials:NCT00087633REPEAT Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Therapy in Combination With COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Who Did Not Respond to Previous PegIntron (Peginterferon Alfa-2b (12KD))/Ribavirin Combination Therapy [clinicaltrials:NCT00087646]Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C [clinicaltrials:NCT00088504]Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment Naive [clinicaltrials:NCT00093093]Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults [clinicaltrials:NCT00100581]Latino Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) in Treatment-Naive Patients With Chronic Hepatitis C-Genotype 1. [clinicaltrials:NCT00107653]48 Weeks Combination Therapy for Patients With HBeAg-negative Chronic Hepatitis B Virus (HBV) Infection [clinicaltrials:NCT00114361]Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and Hepatitis C [clinicaltrials:NCT00122616]Peginterferon Alfa-2a, Ribavirin, Amantadine/Placebo in Hepatitis C Virus (HCV)-Genotype-1-Infection (PRAMA) [clinicaltrials:NCT00127777]clinicaltrials:NCT00136318Multicenter Study Evaluating 12 Versus 24 Weeks Therapy With Peginterferon and Ribavirin for Hepatitis C Virus (HCV) Genotype 2 or 3 [clinicaltrials:NCT00143000]A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Patients With Chronic Hepatitis C [clinicaltrials:NCT00144469]Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C [clinicaltrials:NCT00148863]Analysis of the Duration of Combination Therapy That is Necessary for HCV Genotype 1 Eradication [clinicaltrials:NCT00152581]Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C [clinicaltrials:NCT00154869]Chronic Hepatitis C Treatment by Pegylated Interferon and Ribavirin in Naive Egyptian Patients (ANRS 1211) [clinicaltrials:NCT00158496]clinicaltrials:NCT00158522Interferon Treatment for Patients With Chronic Hepatitis C and End Stage Renal Disease [clinicaltrials:NCT00172809]clinicaltrials:NCT00192569clinicaltrials:NCT00192647Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected Patients [clinicaltrials:NCT00196586]Study of the Pharmacokinetic Action of Amantadine and Ribavirin in Chronic Hepatitis C. CINAM [clinicaltrials:NCT00199719]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Peginterferon alfa-2a [clinicaltrials_resource:ea2504b16a94f43e40b345f0551d81c0]
Bio2RDF identifier
ea2504b16a94f43e40b345f0551d81c0
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ea2504b16a94f43e40b345f0551d81c0
identifier
clinicaltrials_resource:ea2504b16a94f43e40b345f0551d81c0
title
Peginterferon alfa-2a
@en
type
label
Peginterferon alfa-2a [clinicaltrials_resource:ea2504b16a94f43e40b345f0551d81c0]
@en